Ocular Manifestations of the Sturge–Weber Syndrome

Abstract Sturge–Weber syndrome (SWS) or encephalotrigeminal angiomatosis is a non-inherited congenital disorder characterized by neurologic, skin, and ocular abnormalities. A somatic activating mutation (R183Q) in the GNAQ gene during early embryogenesis has been recently recognized as the etiology...

Full description

Bibliographic Details
Main Authors: Kiana Hassanpour, Ramin Nourinia, Ebrahim Gerami, Ghavam Mahmoudi, Hamed Esfandiari
Format: Article
Language:English
Published: Knowledge E 2021-07-01
Series:Journal of Ophthalmic & Vision Research
Subjects:
Online Access:https://doi.org/10.18502/jovr.v16i3.9438
_version_ 1811193857764753408
author Kiana Hassanpour
Ramin Nourinia
Ebrahim Gerami
Ghavam Mahmoudi
Hamed Esfandiari
author_facet Kiana Hassanpour
Ramin Nourinia
Ebrahim Gerami
Ghavam Mahmoudi
Hamed Esfandiari
author_sort Kiana Hassanpour
collection DOAJ
description Abstract Sturge–Weber syndrome (SWS) or encephalotrigeminal angiomatosis is a non-inherited congenital disorder characterized by neurologic, skin, and ocular abnormalities. A somatic activating mutation (R183Q) in the GNAQ gene during early embryogenesis has been recently recognized as the etiology of vascular abnormalities in SWS. Approximately, half of the patients with SWS manifest ocular involvement including glaucoma as the most common ocular abnormality followed by choroidal hemangioma (CH). The underlying pathophysiology of glaucoma in SWS has not been completely understood yet. Early onset glaucoma comprising 60% of SWS glaucoma have lower success rates after medical and surgical treatments compared with primary congenital glaucoma. Primary angle surgery is associated with modest success in the early onset SWS glaucoma while the success rate significantly decreases in late onset glaucoma. Filtration surgery is associated with a higher risk of intraoperative and postoperative choroidal effusion and suprachoroidal hemorrhage. CH is reported in 40–50% of SWS patients. The goal of treatment in patients with CH is to induce involution of the hemangioma, with reduction of subretinal and intraretinal fluid and minimal damage to the neurosensory retina. The decision for treating diffuse CHs highly depends on the patient's visual acuity, the need for glaucoma surgery, the presence of subretinal fluid (SRF), its chronicity, and the potential for visual recovery.
first_indexed 2024-04-12T00:16:26Z
format Article
id doaj.art-f2d73dcf94a9455aa1ed5960aaeb440a
institution Directory Open Access Journal
issn 2008-2010
2008-322X
language English
last_indexed 2024-04-12T00:16:26Z
publishDate 2021-07-01
publisher Knowledge E
record_format Article
series Journal of Ophthalmic & Vision Research
spelling doaj.art-f2d73dcf94a9455aa1ed5960aaeb440a2022-12-22T03:55:49ZengKnowledge EJournal of Ophthalmic & Vision Research2008-20102008-322X2021-07-0116341543110.18502/jovr.v16i3.9438jovr.v16i3.9438Ocular Manifestations of the Sturge–Weber SyndromeKiana Hassanpour0Ramin Nourinia1Ebrahim Gerami2Ghavam Mahmoudi3Hamed Esfandiari4 Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran Ophthalmic Research Center, Research Institute for Ophthalmology and Vision Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran Department of Ophthalmology, Northwestern University Feinberg School of Medicine, Chicago, IL, USAAbstract Sturge–Weber syndrome (SWS) or encephalotrigeminal angiomatosis is a non-inherited congenital disorder characterized by neurologic, skin, and ocular abnormalities. A somatic activating mutation (R183Q) in the GNAQ gene during early embryogenesis has been recently recognized as the etiology of vascular abnormalities in SWS. Approximately, half of the patients with SWS manifest ocular involvement including glaucoma as the most common ocular abnormality followed by choroidal hemangioma (CH). The underlying pathophysiology of glaucoma in SWS has not been completely understood yet. Early onset glaucoma comprising 60% of SWS glaucoma have lower success rates after medical and surgical treatments compared with primary congenital glaucoma. Primary angle surgery is associated with modest success in the early onset SWS glaucoma while the success rate significantly decreases in late onset glaucoma. Filtration surgery is associated with a higher risk of intraoperative and postoperative choroidal effusion and suprachoroidal hemorrhage. CH is reported in 40–50% of SWS patients. The goal of treatment in patients with CH is to induce involution of the hemangioma, with reduction of subretinal and intraretinal fluid and minimal damage to the neurosensory retina. The decision for treating diffuse CHs highly depends on the patient's visual acuity, the need for glaucoma surgery, the presence of subretinal fluid (SRF), its chronicity, and the potential for visual recovery.https://doi.org/10.18502/jovr.v16i3.9438choroidal hemangiomaglaucomaocular manifestationssturge-weber syndrome
spellingShingle Kiana Hassanpour
Ramin Nourinia
Ebrahim Gerami
Ghavam Mahmoudi
Hamed Esfandiari
Ocular Manifestations of the Sturge–Weber Syndrome
Journal of Ophthalmic & Vision Research
choroidal hemangioma
glaucoma
ocular manifestations
sturge-weber syndrome
title Ocular Manifestations of the Sturge–Weber Syndrome
title_full Ocular Manifestations of the Sturge–Weber Syndrome
title_fullStr Ocular Manifestations of the Sturge–Weber Syndrome
title_full_unstemmed Ocular Manifestations of the Sturge–Weber Syndrome
title_short Ocular Manifestations of the Sturge–Weber Syndrome
title_sort ocular manifestations of the sturge weber syndrome
topic choroidal hemangioma
glaucoma
ocular manifestations
sturge-weber syndrome
url https://doi.org/10.18502/jovr.v16i3.9438
work_keys_str_mv AT kianahassanpour ocularmanifestationsofthesturgewebersyndrome
AT raminnourinia ocularmanifestationsofthesturgewebersyndrome
AT ebrahimgerami ocularmanifestationsofthesturgewebersyndrome
AT ghavammahmoudi ocularmanifestationsofthesturgewebersyndrome
AT hamedesfandiari ocularmanifestationsofthesturgewebersyndrome